Photo credit: John Griffin/SBU Communications | Left to right: Jeronimo Cello, Eckard Wimmer, Dr. Benjamin Hsiao and Sean Boykevisch, Sr. Stony Brook University's team of researchers led by Wimmer and Cello executed a research and exclusive option license agreement for the development of a new inactivated polio virus vaccine based on the novel polio viral seed strains developed by the team.
No disease in the first half of the 20th century struck fear the way polio did.
Highly contagious, paralytic, crippling and, in some instances, deadly, it was a seasonal menace that required a titanic scientific effort to identify the tiny virus and contain its spread through vaccines.
Eradicated since 1979 in the United States, the disease exists in only three countries -- Afghanistan,...
Content Preview This content is exclusive for Newsday digital access and 7-day home delivery subscribers and Optimum Online customers.